Evidence map›Paper›PMID 32106578›Full record

ArticleSensors (Basel, Switzerland)2020

Nanocomposite based on Poly (para-phenylene)/Chemical Reduced Graphene Oxide as a Platform for Simultaneous Detection of Ascorbic Acid, Dopamine and Uric Acid.

Zouhour Hsine, Salma Bizid, Rym Milka, Hélène Sauriat-Dorizon, Ayoub Haj Said, Hafsa Korri-Youssoufi

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zouhour HsineUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Equipe de Chimie Biorganique et Bioinorganique (ECBB), Bât 420, 2 Rue du Doyen Georges Poitou, 91400 Orsay, France.
Salma BizidLaboratory of Interfaces and Advanced Materials, Faculty of Science of Monastir, University of Monastir, Monastir 5019, Tunisia.
Rym MilkaLaboratory of Interfaces and Advanced Materials, Faculty of Science of Monastir, University of Monastir, Monastir 5019, Tunisia.
Hélène Sauriat-DorizonUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Equipe de Chimie Biorganique et Bioinorganique (ECBB), Bât 420, 2 Rue du Doyen Georges Poitou, 91400 Orsay, France.
Ayoub Haj SaidLaboratory of Interfaces and Advanced Materials, Faculty of Science of Monastir, University of Monastir, Monastir 5019, Tunisia.
Hafsa Korri-YoussoufiUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Equipe de Chimie Biorganique et Bioinorganique (ECBB), Bât 420, 2 Rue du Doyen Georges Poitou, 91400 Orsay, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, an efficient and simple designed nanohybrid created for individual and simultaneous detection of ascorbic acid (AA), dopamine (DA) and uric acid (UA). This nanohybrid is a combination of reduced graphene oxide (CRGO) and redox poly(para-phenylene) (Fc-ac-PP) modified in a lateral position with ferrrocenyl group CRGO/Fc-ac-PPP. The CRGO/Fc-ac-PPP nanohybrid demonstrated a synergistic effect resulting in a large conductivity, surface area and catalytic properties provided by the redox attached ferrocene. Moreover, this nanocomposite is able to detect individually as well as simultaneously AA, DA and UA in a co-existence system with defined and separated redox peaks oxidation. The linear response ranges for AA, DA and UA, when detected simultaneously, are 0.1-10000 μM, 0.0001-1000 μM and 0.1-10000 μM, respectively, and the detection limits (S/N = 3) are 0.046 μM, 0.2 nM and 0.013 μM, respectively. The proposed sensor shown satisfactory results when applied to real spiked urine samples for measuring the abnormal high or lowconcentration of AA, DA and UA in vivo.

Indexed as

Ascorbic AcidBiosensing TechniquesCycloparaffinsDopamineElectrochemical TechniquesElectrodesFerrous CompoundsGraphiteHumansMacrocyclic CompoundsMetallocenesNanocompositesOxidation-ReductionReproducibility of ResultsUric AcidAscorbic AcidCycloparaffinsDopamineferroceneFerrous Compoundsgraphene oxideGraphiteMacrocyclic CompoundsMetallocenespoly-para-phenyleneUric Acidascorbic aciddopaminenanocompositepoly(paraphenylene)reduced graphene oxideuric acidurine

Identifiers

PMID32106578
PMCPMC7085538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.